At the Translational Microbiome Conference (TMC) in Boston this May, a discussion panel, moderated by DNA Genotek’s Aaron Del Duca, covered the new and expanding field of multiomics. The panel consisted of Dr. Stephan Reiling (Computational Scientist at Kaleido), Dr. Annie Evans (Director of R&D at Metabolon), Dr. Dan Knights (CEO and Co-Founder of CoreBiome), and Dr. David Riglar (Post-Doctoral Fellow in the Department of Systems Biology, Harvard).Read More
DNA Genotek's Microbiome Collection and Stabilization Blog
Most people consider the nature of collecting fecal samples unpleasant and inconvenient. One of the challenges for the researcher conducting a gut microbiome study, is to provide the participants with a comprehensive and simple collection procedure without compromising the integrity of the sample. There is a mountain of data on collection methods, temperature holds, stabilizers vs fresh, individual chemistries, effects of freezing on viability, and DNA integrity…how can we make sense out of this often conflicting data?
In this second segment to our three part cold chain stool sample collection series (click here to read part 1), we explore where error and bias can be introduced when using cold-chain sample collection and transportation of stool samples. We look at two important factors regarding stool collection for microbiome research: simplicity and stability.Read More
We had the opportunity to sit down with Aaron Del Duca, our VP Technology and Microbiome Program Lead to discuss a few trends in the microbiome field he’s most excited about. Aaron has spent the past 4 years engaging with scientists in academia and industry to understand what the biggest constraints to discovery are, and sharing insights and best practices at microbiome conferences and with standards organizations around the globe. Below, we’ve condensed Aaron’s take on five exciting developments and on-going challenges in the microbiome space.Read More
If you are a frequent reader of The Microbiome Snapshot, you know that research into the human microbiome has emerged as highly informative to our overall understanding of health and disease risk. The growth in microbiome research has been fueled by many factors including the improvement of sequencing technologies and new computational methods. However, the impact of these methods have been somewhat limited by various factors such as precision, resolution, scalability and usability.Read More